Audio-based digital biomarkers in diagnosing and managing respiratory diseases: a systematic review and bibliometric analysis.

IF 9 1区 医学 Q1 RESPIRATORY SYSTEM
European Respiratory Review Pub Date : 2025-05-14 Print Date: 2025-04-01 DOI:10.1183/16000617.0246-2024
Vivianne Landry, Jessica Matschek, Roger Pang, Meghana Munipalle, Kenneth Tan, Jill Boruff, Nicole Y K Li-Jessen
{"title":"Audio-based digital biomarkers in diagnosing and managing respiratory diseases: a systematic review and bibliometric analysis.","authors":"Vivianne Landry, Jessica Matschek, Roger Pang, Meghana Munipalle, Kenneth Tan, Jill Boruff, Nicole Y K Li-Jessen","doi":"10.1183/16000617.0246-2024","DOIUrl":null,"url":null,"abstract":"<p><p>Advances in wearable sensors and artificial intelligence have greatly enhanced the potential of digitised audio biomarkers for disease diagnostics and monitoring. In respiratory care, evidence supporting their clinical use remains fragmented and inconclusive. This study aimed to assess the current research landscape of digital audio biomarkers in respiratory medicine through a bibliometric analysis and systematic review (PROSPERO CRD 42022336730). MEDLINE, Embase, Cochrane Library and CINAHL were searched for references indexed up to 9 April 2024. Eligible studies evaluated the accuracy of sound analysis for diagnosing and managing obstructive (asthma and COPD) or infectious respiratory diseases, excluding COVID-19. A narrative synthesis was conducted, and the QUADAS-2 tool was used to assess study quality and risk of bias. Of 14 180 studies, 81 were included. Bibliometric analysis identified fundamental (<i>e.g.</i> \"diagnostic accuracy\"+\"machine learning\") and emerging (<i>e.g.</i> \"developing countries\") themes. Despite methodological heterogeneity, audio biomarkers generally achieved moderate (60-79%) to high (80-100%) accuracies. 80% of studies (eight out of ten) reported high sensitivities and specificities for asthma diagnosis, 78% (seven out of nine) reported high sensitivities and 56% (five out of nine) reported high specificities for COPD, and 64% (seven out of eleven) reported high sensitivity or specificity values for pneumonia diagnosis. Breathing and coughing were the most common biomarkers, with artificial neural networks being the most common analysis technique. Future research on audio biomarkers should focus on testing their validity in clinically diverse populations and resolving algorithmic bias. If successful, digital audio biomarkers hold promise for complementing existing clinical tools in enabling more accessible applications in telemedicine, communicable disease monitoring, and chronic condition management.</p>","PeriodicalId":12166,"journal":{"name":"European Respiratory Review","volume":"34 176","pages":""},"PeriodicalIF":9.0000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12076160/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/16000617.0246-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"Print","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Advances in wearable sensors and artificial intelligence have greatly enhanced the potential of digitised audio biomarkers for disease diagnostics and monitoring. In respiratory care, evidence supporting their clinical use remains fragmented and inconclusive. This study aimed to assess the current research landscape of digital audio biomarkers in respiratory medicine through a bibliometric analysis and systematic review (PROSPERO CRD 42022336730). MEDLINE, Embase, Cochrane Library and CINAHL were searched for references indexed up to 9 April 2024. Eligible studies evaluated the accuracy of sound analysis for diagnosing and managing obstructive (asthma and COPD) or infectious respiratory diseases, excluding COVID-19. A narrative synthesis was conducted, and the QUADAS-2 tool was used to assess study quality and risk of bias. Of 14 180 studies, 81 were included. Bibliometric analysis identified fundamental (e.g. "diagnostic accuracy"+"machine learning") and emerging (e.g. "developing countries") themes. Despite methodological heterogeneity, audio biomarkers generally achieved moderate (60-79%) to high (80-100%) accuracies. 80% of studies (eight out of ten) reported high sensitivities and specificities for asthma diagnosis, 78% (seven out of nine) reported high sensitivities and 56% (five out of nine) reported high specificities for COPD, and 64% (seven out of eleven) reported high sensitivity or specificity values for pneumonia diagnosis. Breathing and coughing were the most common biomarkers, with artificial neural networks being the most common analysis technique. Future research on audio biomarkers should focus on testing their validity in clinically diverse populations and resolving algorithmic bias. If successful, digital audio biomarkers hold promise for complementing existing clinical tools in enabling more accessible applications in telemedicine, communicable disease monitoring, and chronic condition management.

基于音频的数字生物标志物在诊断和管理呼吸系统疾病:系统综述和文献计量学分析。
可穿戴传感器和人工智能的进步极大地增强了数字化音频生物标志物在疾病诊断和监测方面的潜力。在呼吸保健方面,支持其临床应用的证据仍然零散且不确定。本研究旨在通过文献计量学分析和系统评价(PROSPERO CRD 42022336730)来评估呼吸医学中数字音频生物标志物的研究现状。检索检索截止到2024年4月9日的MEDLINE、Embase、Cochrane Library和CINAHL。符合条件的研究评估了声音分析诊断和治疗阻塞性(哮喘和慢性阻塞性肺病)或传染性呼吸道疾病(不包括COVID-19)的准确性。进行叙述性综合,并使用QUADAS-2工具评估研究质量和偏倚风险。在14180项研究中,纳入了81项。文献计量学分析确定了基本的(例如:“诊断准确性”+“机器学习”)和新兴(例如:“发展中国家”)主题。尽管方法存在异质性,但音频生物标记物通常具有中等(60-79%)至高(80-100%)的准确性。80%的研究(10项研究中有8项)报告了哮喘诊断的高敏感性和特异性,78%(9项研究中有7项)报告了COPD的高敏感性,56%(9项研究中有5项)报告了COPD的高特异性,64%(11项研究中有7项)报告了肺炎诊断的高敏感性或特异性。呼吸和咳嗽是最常见的生物标志物,人工神经网络是最常见的分析技术。未来对音频生物标志物的研究应侧重于在临床不同人群中测试其有效性,并解决算法偏差。如果成功,数字音频生物标志物有望补充现有的临床工具,使远程医疗、传染病监测和慢性病管理等领域的应用更容易获得。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Respiratory Review
European Respiratory Review Medicine-Pulmonary and Respiratory Medicine
CiteScore
14.40
自引率
1.30%
发文量
91
审稿时长
24 weeks
期刊介绍: The European Respiratory Review (ERR) is an open-access journal published by the European Respiratory Society (ERS), serving as a vital resource for respiratory professionals by delivering updates on medicine, science, and surgery in the field. ERR features state-of-the-art review articles, editorials, correspondence, and summaries of recent research findings and studies covering a wide range of topics including COPD, asthma, pulmonary hypertension, interstitial lung disease, lung cancer, tuberculosis, and pulmonary infections. Articles are published continuously and compiled into quarterly issues within a single annual volume.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信